Prior to joining NALCO, Singh was serving as General Manager (Materials & Contracts) and In-charge (HR) at Hindustan Copper ...
The way brands communicate with consumers has evolved rapidly over the last decade. Traditional advertising alone is no ...
ISELIN, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company ...
Asahi's yeast-based milk alternative became a top-selling product and will be rolled out to more retailers in 2026.
Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the ...
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for ...
Experienced Industry Leader with More than Two Decades of Global Commercialization and Marketing Expertise SAN DIEGO, Jan. 7, 2026 /PRNewswire/ -- Viking Therapeutics ...
Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...
FDA feedback supports 505(b)(2) filing in H2 2026; No additional studies required beyond current planned 32-subject clinical ...
It’s not only about asking questions; it’s about asking the right ones. They can make or break a product’s success in the ...
Under the terms of the agreement, Caring Brands will assume responsibility for product manufacturing, marketing, sales ...
Shortly after scoring a historic FDA nod for its Wegovy pill, Novo Nordisk is off to the races with the oral obesity med’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback